Oezlem Karalay obtained M.Sc. degree in Neuroscience from MPI for Developmental Biology, Tubingen. She received her doctorate in Neuroscience from the Swiss Federal Institute of Technology (ETH), Zurich. She joined QIAGEN after completion of her postdoctoral research at the MPI for Biology of Ageing, Cologne, and since then has been involved in developing the digital PCR assay portfolio, including mutation detection and CNV assays.
Health Monitoring Showcase:
QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins. We deliver Sample to Insight solutions for molecular testing, propelling our customers from start to finish to unlock new insights.
Detection of rare events in liquid biopsy samples using QIAcuity Digital PCR system
“Detection of rare events in liquid biopsy samples using QIAcuity Digital PCR system”
Session Abstract – PMWC 2023 Silicon Valley
The PMWC 2023 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.